
Enlivex Therapeutics Ltd. ENLV
€ 0.72
-13.15%
Geschäftsbericht 2025
hinzugefügt 11.04.2026
Enlivex Therapeutics Ltd. PEG 2011-2026 | ENLV
PEG Jährlich Enlivex Therapeutics Ltd.
| 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| -0.232 | -1.18 | 1.62 | -0.0454 | -0.0395 | -0.0237 | -0.214 | 0.0379 | 0.0331 | - | - | - |
Alle Zahlen in USD-Währung
Indikatorenreichweite aus Jahresberichten
| Höchstwert | Mindestwert | Durchschnitt |
|---|---|---|
| 1.62 | -1.18 | -0.00423 |
PEG anderer Aktien in der Pharmaeinzelhändler
| Name | PEG | Preis | % 24h | Marktkapitalisierung | Land | |
|---|---|---|---|---|---|---|
|
MorphoSys AG
MOR
|
-0.169 | - | 2.43 % | $ 254 M | ||
|
Aligos Therapeutics
ALGS
|
0.0282 | $ 8.48 | 6.0 % | $ 83.8 M | ||
|
Alterity Therapeutics Limited
ATHE
|
-0.0509 | $ 3.66 | -1.48 % | $ 8.81 B | ||
|
I-Mab
IMAB
|
-0.75 | - | - | $ 866 M | ||
|
AlloVir
ALVR
|
0.1 | - | 4.14 % | $ 49.1 M | ||
|
Applied Molecular Transport
AMTI
|
0.133 | - | - | $ 10.1 M | ||
|
Alexion Pharmaceuticals, Inc.
ALXN
|
-0.747 | - | - | $ 40.3 B | ||
|
Genfit SA
GNFT
|
-0.0281 | - | 2.54 % | $ 160 B | ||
|
Esperion Therapeutics
ESPR
|
0.799 | $ 2.19 | 0.92 % | $ 455 M | ||
|
Evogene Ltd.
EVGN
|
-1.63 | $ 0.78 | -4.39 % | $ 27.9 M | ||
|
Applied Therapeutics
APLT
|
0.243 | - | - | $ 8.42 M | ||
|
EyeGate Pharmaceuticals, Inc.
EYEG
|
0.254 | - | -1.52 % | $ 24.7 M | ||
|
Midatech Pharma plc
MTP
|
-0.0114 | - | -18.52 % | $ 27.3 M | ||
|
Genmab A/S
GMAB
|
0.277 | $ 28.2 | -0.18 % | $ 18 B | ||
|
Grifols, S.A.
GRFS
|
-0.077 | $ 8.38 | 2.01 % | $ 6.83 B | ||
|
GT Biopharma
GTBP
|
-0.00067 | $ 0.38 | 2.47 % | $ 2.1 M | ||
|
Amphastar Pharmaceuticals
AMPH
|
0.154 | $ 21.28 | 4.44 % | $ 995 M | ||
|
Halozyme Therapeutics
HALO
|
0.872 | $ 66.92 | -1.33 % | $ 8.02 B | ||
|
Acorda Therapeutics
ACOR
|
-0.000047 | - | -24.86 % | $ 820 K | ||
|
Институт стволовых клеток человека
ISKJ
|
-2.8 | - | - | - | ||
|
Adverum Biotechnologies
ADVM
|
-0.00407 | - | - | $ 86.2 M | ||
|
Harmony Biosciences Holdings
HRMY
|
0.631 | $ 29.05 | 0.55 % | $ 1.67 B | ||
|
Advaxis
ADXS
|
-0.000022 | - | -9.65 % | $ 45.9 M | ||
|
Aeterna Zentaris
AEZS
|
0.0493 | - | 5.93 % | $ 314 M | ||
|
AgeX Therapeutics
AGE
|
-0.51 | - | -10.17 % | $ 12.2 K | ||
|
Immatics N.V.
IMTX
|
2.14 K | $ 10.87 | 4.17 % | $ 684 M | ||
|
Incyte Corporation
INCY
|
0.135 | $ 95.33 | -0.77 % | $ 18.6 B | ||
|
Aeglea BioTherapeutics
AGLE
|
-0.0134 | - | - | $ 1.01 B | ||
|
Akebia Therapeutics
AKBA
|
1.02 | $ 1.46 | 4.29 % | $ 375 M | ||
|
Applied Genetic Technologies Corporation
AGTC
|
0.00894 | - | - | $ 26.5 M | ||
|
Allakos
ALLK
|
0.664 | - | - | $ 28.6 M | ||
|
Can-Fite BioPharma Ltd.
CANF
|
-0.000013 | $ 2.99 | 2.4 % | $ 4.92 M | ||
|
Aptinyx
APTX
|
-0.0809 | - | -39.0 % | $ 4.57 M | ||
|
Aquestive Therapeutics
AQST
|
-0.64 | $ 4.2 | 2.82 % | $ 449 M | ||
|
Aravive
ARAV
|
0.0342 | - | -13.39 % | $ 1.45 M | ||
|
Arcutis Biotherapeutics
ARQT
|
0.0316 | $ 24.24 | 0.1 % | $ 3.08 B | ||
|
Innate Pharma S.A.
IPHA
|
-0.0174 | $ 1.47 | 4.26 % | $ 235 M | ||
|
AIkido Pharma
AIKI
|
-0.000778 | - | 1.93 % | $ 17.4 M | ||
|
Celldex Therapeutics
CLDX
|
1.27 | $ 32.59 | 1.09 % | $ 2.16 B | ||
|
Autolus Therapeutics plc
AUTL
|
0.0594 | $ 1.48 | -0.67 % | $ 394 M | ||
|
Aptose Biosciences
APTO
|
-0.000164 | - | -45.71 % | $ 1.2 M | ||
|
Cidara Therapeutics
CDTX
|
-0.00298 | - | - | $ 1.41 B | ||
|
AVROBIO
AVRO
|
0.068 | - | 1083.1 % | $ 745 M | ||
|
Ayala Pharmaceuticals
AYLA
|
0.0783 | - | - | $ 7.46 M | ||
|
AstraZeneca PLC
AZN
|
-369 | - | - | $ 96.9 B | ||
|
Akero Therapeutics
AKRO
|
-0.964 | - | - | $ 3.67 B | ||
|
CureVac N.V.
CVAC
|
4.05 | - | - | $ 867 M | ||
|
Brainstorm Cell Therapeutics
BCLI
|
-0.00304 | - | -2.5 % | $ 5.88 M | ||
|
BeiGene, Ltd.
BGNE
|
9.68 | - | 0.49 % | $ 251 B |